Search
Dasatinib anhydrous for sale is used in chronic myeloid leukemia that is resistant or intolerable to treatment regimens including imatinib mesylate.
Dasatinib anhydrous is a protein kinase inhibitor that inhibits BCR-ABL kinase and SRC family kinases and many other selective oncogenic kinases, including c-KIT, ephrin (EPH) receptor kinase, and PDGFβ receptor, dasatinib anhydrous primarily treats adult patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) chronic, accelerated, and blast phase (acute granulosis and blast leaching) resistant to imatinib mesylate, or intolerance.
| Items | Specifications | Results |
| Appearance | White powder | Conforms |
| Assay | ≥99.0% | 99.63% |
| Product parameters | |
| Cas number: | 302962-49-8 |
| Appearance: | White powder |
| Purity: | 99%min |
| Package details: | 100g/bottle; 1kg/foil bag |
| Brand: | Fortunachem |

Suitable for treatment of chronic myeloid leukemia.

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية